Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patientsA W Tolcher, K H Cowan, M H Noone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedbackG P Browman, T E Newman, E A Mohide, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluationsJ A Lawrence, P C Adamson, R Caruso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
A phase I study of topotecan followed sequentially by doxorubicin in patients with advanced malignanciesA W Tolcher, J A O'Shaughnessy, R B Weiss, et al.
Molecular and Cellular Biology|August 18, 2006
Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1Rebecca S Muraoka-Cook, Laura S Caskey, Melissa A Sandahl, et al.
Breast Cancer Research and Treatment|January 5, 2000
Tamoxifen and fenretinide in women with metastatic breast cancerJ Zujewski, L Pai, L Wakefield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancerB Conley, J O'Shaughnessy, S Prindiville, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancerA W Tolcher, K H Cowan, D Solomon, et al.
Pageof 25